Hideyo Hirai

4.5k citations

105 papers · 3.4k indexed · h-index 33

Impact in

Hematology top 1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Immunology top 2%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- Immunotherapy and Immune Responses
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms

Papers in

Hematology 49
- Acute Myeloid Leukemia Research 22
- Chronic Myeloid Leukemia Treatments 18
- Hematopoietic Stem Cell Transplantation 11
Genetics 21
- Mesenchymal stem cell research 10
- Chronic Lymphocytic Leukemia Research 8

Co-authors: Jirô Imanishi Taira Maekawa Daniel G. Tenen Eishi Ashihara Koichi Akashi Chihiro Shimazaki Pu Zhang Tajhal Dayaram
Journals: Blood (18 papers)Biochemical and Biophysical Research Communications (8 papers)Cancer Letters (6 papers)International Journal of Hematology (4 papers)Clinical Cancer Research (3 papers)
Partner nations: Japan United States Singapore

In The Last Decade

Hideyo Hirai

104 papers receiving 3.3k citations

Peers

Countries citing papers authored by Hideyo Hirai

Since Specialization

Citations

This map shows the geographic impact of Hideyo Hirai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyo Hirai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyo Hirai more than expected).

Fields of papers citing papers by Hideyo Hirai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideyo Hirai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyo Hirai. The network helps show where Hideyo Hirai may publish in the future.

Co-authors

The 25 scholars most cited alongside Hideyo Hirai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hideyo Hirai Line = papers co-authored together Hideyo Hirai links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Reduced lung metastasis in endothelial cell-specific transforming growth factor β type II receptor-deficient mice with decreased CD44 expression iScience ·F. D. Kern, Yuki Saito, Dioscoro M. Melana, R. Sekhar, 魏水华, 正之島, Hideyo Hirai, Marcus Fruttiger, 秀晃須賀, Fumiko Itoh	2024	0
2	Hematopoietic stem cells undergo a lymphoid to myeloid switch in early stages of emergency granulopoiesis The EMBO Journal ·張四友, J R Phillips, J.P. Wils, Irene Lopez-Arribas, Asumi Yokota, Wu Weiqian, M. L. Capitaine, Jess McCann Thomsen, Dariusz Plewczyński, Jakub Rohlena, Hideyo Hirai, Kateřina Rohlenová, Meritxell Alberich-Jordà	2023	6
3	C/EBPβ isoforms sequentially regulate regenerating mouse hematopoietic stem/progenitor cells Blood Advances ·Atsushi Satō, Yoshitaka Hori, Asumi Yokota, Yoshihiro Hayashi, Akihiro Tamura, Yasuo Miura, Taira Maekawa, Hideyo Hirai	2020	23
4	Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8–CXCR2 Axis Clinical Cancer Research ·Ryotaro Ogawa, Takamasa Yamamoto, Hideyo Hirai, Lionel Ortiz-Fuentes, Yoshiyuki Kiyasu, Gen Nishikawa, Rei Mizuno, Susumu Inamoto, Yoshiro Itatani, Yoshiharu Sakai, Kenji Kawada	2019	108
5	Impact of Antibodies That React With Liver Tissue and Donor-Specific Anti-HLA Antibodies in Pediatric Idiopathic Posttransplantation Hepatitis Transplantation ·Yoshihiro Hirata, Atsushi Yoshizawa, Hiroto Egawa, Daisuke Ueda, Shinya Okamoto, Hideaki Okajima, Kimiko Yurugi, N. Focks, Hideyo Hirai, Aya Miyagawa‐Hayashino, Taira Maekawa, Hironori Haga, Secretaria de Estado de Cultura do Rio de Janeiro	2017	7
6	Loss of SMAD4 Promotes Lung Metastasis of Colorectal Cancer by Accumulation of CCR1+ Tumor-Associated Neutrophils through CCL15-CCR1 Axis Clinical Cancer Research ·Takamasa Yamamoto, Kenji Kawada, Yoshiro Itatani, Susumu Inamoto, Ryosuke Okamura, Masayoshi Iwamoto, Ei Miyamoto, Toyofumi F. Chen‐Yoshikawa, Hideyo Hirai, Suguru Hasegawa, Putri Novita Krisnawanty, Makoto M. Taketo, Yoshiharu Sakai	2016	75
7	Loss of SMAD4 Promotes Colorectal Cancer Progression by Accumulation of Myeloid-Derived Suppressor Cells through the CCL15–CCR1 Chemokine Axis Clinical Cancer Research ·Susumu Inamoto, Yoshiro Itatani, Takamasa Yamamoto, Sachiko Minamiguchi, Hideyo Hirai, Masayoshi Iwamoto, Suguru Hasegawa, Makoto M. Taketo, Yoshiharu Sakai, Kenji Kawada	2015	106
8	Parathyroid Hormone Enhances Hematopoietic Expansion Via Upregulation of Cadherin-11 in Bone Marrow Mesenchymal Stromal Cells Stem Cells ·Hisayuki Yao, Yasuo Miura, Satoshi Yoshioka, Masako Miura, Yoshihiro Hayashi, Akihiro Tamura, Yuanzhe Li, Atsushi Satō, Amanda Bodenarain, Esmat Dusti, Hitomi Kaneko, Eishi Ashihara, Tatsuo Ichinohe, Hideyo Hirai, Taira Maekawa	2014	24
9	Myeloid-Derived Suppressor Cells Play Crucial Roles in the Regulation of Mouse Collagen-Induced Arthritis The Journal of Immunology ·Wataru Fujii, Eishi Ashihara, Hideyo Hirai, Hidetake Nagahara, Naoko Kajitani, Yu.F. Knizilinikov, Ken Murakami, Takahiro Seno, Aihiro Yamamoto, Hidetaka Ishino, Masataka Kohno, Taira Maekawa, Yutaka Kawahito	2013	129
10	Rapid automated detection of ABL kinase domain mutations in imatinib-resistant patients Cancer Letters ·Ruriko Tanaka, Shinya Kimura, Eishi Ashihara, Mariko Yoshimura, Naoto Takahashi, Hisashi Wakita, Kuniaki Itoh, Kaichi Nishiwaki, Kenshi Suzuki, Rina Nagao, Hisayuki Yao, Yoshihiro Hayashi, Brian Andrew Cole, Hideyo Hirai, Ken-ichi Sawada, Oliver G. Ottmann, Junia V. Melo, Taira Maekawa	2011	15
11	Early Protective Effect of Bone Marrow Mononuclear Cells Against Ischemic White Matter Damage Through Augmentation of Cerebral Blood Flow Stroke ·Youshi Fujita, Masafumi Ihara, Takashi Ushiki, Hideyo Hirai, Shinae Kizaka‐Kondoh, Masahiro Hiraoka, Hidefumi Ito, Ryōsuke Takahashi	2010	54
12	A combination of a DNA-chimera siRNA against PLK-1 and zoledronic acid suppresses the growth of malignant mesothelioma cells in vitro Cancer Letters ·Abdolnasser Rostami, Eishi Ashihara, Yoko Nakagawa, Takahiro Kiuchi, E. Hartung, Hisayuki Yao, Lailla Vicens Jm, Ruriko Tanaka, Rina Nagao, Asumi Yokota, Miki Takeuchi, Shinya Kimura, Hideyo Hirai, Taira Maekawa	2010	13
13	Galectin‐9 ameliorates acute GVH disease through the induction of T‐cell apoptosis European Journal of Immunology ·Lailla Vicens Jm, Eri Kawata, Eishi Ashihara, Yoko Nakagawa, Akira Yamauchi, Hisayuki Yao, Rina Nagao, Ruriko Tanaka, Asumi Yokota, Miki Takeuchi, Hideyo Hirai, Shinya Kimura, Mitsuomi Hirashima, Norio Yoshimura, Taira Maekawa	2010	40
14	Combination vaccine of dendritic cells (DCs) and T cells effectively suppressed preestablished malignant melanoma in mice Cancer Letters ·Hidetsugu Asada, Tsunao Kishida, Hideyo Hirai, Masaharu Shin‐Ya, Jirô Imanishi, Minoru Takeuchi, Osam Mazda	2005	7
15	Interleukin-2 Abolishes Myeloid Cell Accumulation Induced by Lewis Lung Carcinoma Journal of Interferon & Cytokine Research ·Masaharu Shin‐Ya, Osam Mazda, 马英杰 MA Yingjie, Hideyo Hirai, Jirô Imanishi, Minoru Takeuchi	2003	5
16	Significant Antitumor Effects Obtained by Autologous Tumor Cell Vaccine Engineered to Secrete Interleukin (IL)-12 and IL-18 by Means of the EBV/Lipoplex Molecular Therapy ·Hidetsugu Asada, Tsunao Kishida, Hideyo Hirai, Etsuko Satoh, Suzuyo Ohashi, Minoru Takeuchi, Toshikazu Kubo, Masakazu Kita, Yoichiro Iwakura, Jirô Imanishi, Osam Mazda	2002	44
17	A newly developed bisphosphonate, YM529, is a potent apoptosis inducer of human myeloma cells Leukemia Research ·Ryoichi Takahashi, Chihiro Shimazaki, Tohru Inaba, Akira Okano, J. H. Feng, Akio Okamoto, Hideyo Hirai, Terumi Namiki, Masao Nakagawa	2001	50
18	B‐cell lymphoma associated with haemophagocytic syndrome: a clinical, immunological and cytogenetic study British Journal of Haematology ·Chihiro Shimazaki, MO Xiu-hon, Kazuho Shimura, Akio Okamoto, Ryoichi Takahashi, Hideyo Hirai, Yoshikazu Sudo, Eishi Ashihara, Yoko Adachi, Satoshi Murakami, Katsuyasu Saigo, Naohisa Fujita, Masao Nakagawa	1999	62
19	Serum thrombopoietin levels in patients undergoing autologous peripheral blood stem cell transplantation Bone Marrow Transplantation ·Chihiro Shimazaki, Tohru Inaba, Hiroyuki Uchiyama, Toshiya Sumikuma, R. C. Sarker, Hideyo Hirai, Yoshikazu Sudo, Noboru Yamagata, Eishi Ashihara, Hideo Goto, Asaf Farhi, Yanxi Ye, Naohisa Fujita, Masao Nakagawa	1997	23
20	Disappearance of Ph1 chromosome with intensive chemotherapy and detection of minimal residual disease by polymerase chain reaction in a patient with blast crisis of chronic myelogenous leukemia. PubMed ·H. Honda, Kiyoshi Miyagawa, Thomas Commons, Fumimaro Takaku, Y Yazaki, Hideyo Hirai	1993	2

About Hideyo Hirai

Hideyo Hirai is a scholar working on Hematology, Genetics, Immunology, Oncology and Rheumatology, having authored 105 papers that have together received 3.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (22 papers), Chronic Myeloid Leukemia Treatments (18 papers), Immune cells in cancer (17 papers), Immune Cell Function and Interaction (16 papers), Hematopoietic Stem Cell Transplantation (11 papers), Mesenchymal stem cell research (10 papers), Immune Response and Inflammation (10 papers) and Chronic Lymphocytic Leukemia Research (8 papers). The work is most often cited by research in Hematology (794 citations), Immunology (1.4k citations), Genetics (402 citations), Oncology (792 citations) and Cancer Research (356 citations). Hideyo Hirai has collaborated with scholars based in Japan, United States and Singapore. Frequent co-authors include Jirô Imanishi, Taira Maekawa, Daniel G. Tenen, Eishi Ashihara, Koichi Akashi, Chihiro Shimazaki, Pu Zhang, Tajhal Dayaram, Tohru Inaba and Yasuo Miura. Their work appears in journals such as Blood, Biochemical and Biophysical Research Communications, Cancer Letters, International Journal of Hematology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact